Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Albertsson

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 6, 2003
Chemotherapy and antiangiogenesis--drug-specific, dose-related effectsBo Lennernäs, Per Albertsson, Hans Lennernäs, et al.
Clinical Interventions in Aging|February 6, 2015
Elderly patients with myocardial infarction selected for conservative or invasive treatment strategyBerglind Libungan, Thomas Karlsson, Per Albertsson, et al.
Clinical Cardiology|March 18, 2010
Primary percutaneous coronary interventions in nonagenariansMichael Koutouzis, Lars Grip, Göran Matejka, et al.
European Journal of Cardiovascular Nursing|February 5, 2020
Octogenarian preferences and expectations for acute coronary syndrome treatmentCharlotte Widell, Sofie Andréen, Per Albertsson, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 22, 2004
Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative studyBo Lennernäs, Per Albertsson, Jan-Erik Damber, et al.
Frontiers in Oncology|January 25, 2014
The potential and hurdles of targeted alpha therapy - clinical trials and beyondJörgen Elgqvist, Sofia Frost, Jean-Pierre Pouget, et al.
The American Journal of Medicine|March 15, 2011
The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary interventionMarkus Lingman, Per Albertsson, Johan Herlitz, et al.
Oncology Reports|October 20, 2004
The effectiveness of artificial neural networks in evaluating treatment plans for patients requiring external beam radiotherapyBo Lennernäs, Dan Sandberg, Per Albertsson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2010
Radial vs. femoral approach for primary percutaneous coronary intervention in octogenariansMichael Koutouzis, Göran Matejka, Göran Olivecrona, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 14, 2011
Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulationKarin Edsparr, Per H Basse, Ronald H Goldfarb, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|August 6, 2003
Chemotherapy and antiangiogenesis--drug-specific, dose-related effectsBo Lennernäs, Per Albertsson, Hans Lennernäs, et al.
Clinical Interventions in Aging|February 6, 2015
Elderly patients with myocardial infarction selected for conservative or invasive treatment strategyBerglind Libungan, Thomas Karlsson, Per Albertsson, et al.
Clinical Cardiology|March 18, 2010
Primary percutaneous coronary interventions in nonagenariansMichael Koutouzis, Lars Grip, Göran Matejka, et al.
European Journal of Cardiovascular Nursing|February 5, 2020
Octogenarian preferences and expectations for acute coronary syndrome treatmentCharlotte Widell, Sofie Andréen, Per Albertsson, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 22, 2004
Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative studyBo Lennernäs, Per Albertsson, Jan-Erik Damber, et al.
Frontiers in Oncology|January 25, 2014
The potential and hurdles of targeted alpha therapy - clinical trials and beyondJörgen Elgqvist, Sofia Frost, Jean-Pierre Pouget, et al.
The American Journal of Medicine|March 15, 2011
The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary interventionMarkus Lingman, Per Albertsson, Johan Herlitz, et al.
Oncology Reports|October 20, 2004
The effectiveness of artificial neural networks in evaluating treatment plans for patients requiring external beam radiotherapyBo Lennernäs, Dan Sandberg, Per Albertsson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2010
Radial vs. femoral approach for primary percutaneous coronary intervention in octogenariansMichael Koutouzis, Göran Matejka, Göran Olivecrona, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 14, 2011
Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulationKarin Edsparr, Per H Basse, Ronald H Goldfarb, et al.
Pageof 11